Pleiotrophin antagonizes Bromodomain-containing protein 2 (Brd2) during neuronal differentiation
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Bromodomain-containing protein 2 (Brd2) is a BET family chromatin adaptor required for expression of cell cycle associated genes and therefore involved in cell cycle progression. Brd2 is expressed in proliferating neuronal progenitors, displays cell cycle-stimulating activity and, when overexpressed, impairs neuronal differentiation. Paradoxically, Brd2 is also detected in differentiating neurons. To shed light on the role of Brd2 in the transition from cell proliferation to differentiation we have looked for Brd2 interacting proteins upon induction of neuronal differentiation. Surprisingly, we have identified the growth factor Pleiotrophin (Ptn). Ptn antagonizes the cell cycle-stimulating activity associated with Brd2, thus enhancing induced neuronal differentiation. Moreover, Ptn knockdown reduces neuronal differentiation. Ptn-mediated antagonism of Brd2 has been assessed in a cell differentiation model and in two embryonic processes associated with the neural tube: spinal cord neurogenesis and neural crest migration. Finally we have investigated the mechanisms of Ptn-mediated antagonism and determined that Ptn destabilizes Brd2 association with chromatin. Thus, Ptn-Brd2 antagonism emerges as a modulation system accounting for the balance between cell proliferation and differentiation in the vertebrate nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rahman, S., Sowa, M. E., Ottinger, M., Smith, J. A., Shi, Y., Harper, J. W., & Howley, P. M. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01341-10 · Cited by 532 · cited 1×
“Reported interactions of Brd2 with several chromatin co-regulators through the ET domain (Rahman et al., 2011) raise the question of how these factors may alter Ptn function or interaction.”
BackgroundHouzelstein, D., Bullock, S. L., Lynch, D. E., Grigorieva, E. F., Wilson, V. A., & Beddington, R. S. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3794-3802.2002 · Cited by 318 · cited 3×
“Mouse embryonic fibroblasts derived from Brd4 and Brd2 mutant embryos display proliferative defects, which, to a lesser extent, are also observed in heterozygous cells (Houzelstein et al., 2002; Shang et al., 2009).”
BackgroundBrd2 disruption in mice causes severe obesity without Type 2 diabetes
Wang, F., Liu, H., Blanton, W. P., Belkina, A., Lebrasseur, N. K., & Denis, G. V. (2010) · Biochemical Journal · doi:10.1042/bj20090928 · Cited by 185 · cited 3×
“Interestingly, reduced expression of Brd2 in mice produces a distinct hypomorphic phenotype with extreme obesity and hyperinsulinemia, but enhanced glucose tolerance and low blood glucose (Wang et al., 2010).”
BackgroundResultInfluentialDouble bromodomain‐containing gene Brd2 is essential for embryonic development in mouse
Shang, E., Wang, X., Wen, D., Greenberg, D. A., & Wolgemuth, D. J. (2009) · Developmental Dynamics · doi:10.1002/dvdy.21911 · Cited by 156 · cited 10×
“Despite the clear role of Brd2 in cell cycle progression (Denis et al., 2000; Garcia-Gutierrez et al., 2012; LeRoy et al., 2008; Shang et al., 2009; Sinha et al., 2005), expression is also detected in differentiating neurons (Crowley et al., 2004).”
BackgroundSelf-citation
Cited by
A novel microglial subset plays a key role in myelinogenesis in developing brain
Wlodarczyk, A., Holtman, I. R., Krueger, M., Yogev, N., Bruttger, J., Khorooshi, R., Benmamar‐Badel, A., de Boer‐Bergsma, J. J., Martin, N. A., Karram, K., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201696056 · Cited by 535
“Moreover, CD11c + microglia expressed Gpx3 and Ptn that promote neurite outgrowth, Lgals1 promoting axonal growth, neuroprotective Gpnmb, Adam19 known to shed neuregulin isoforms (Fig 6B), and tissue remodeling metalloproteinases: Mmp12, Mmp19 , and Mmp24 (not shown).”
Notaras, M., Lodhi, A., Dündar, F., Collier, P., Sayles, N. M., Tilgner, H., Greening, D., & Colak, D. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01316-6 · Cited by 150
Pleiotrophin: Activity and mechanism
(2020) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2020.02.003 · Cited by 98
Dedifferentiation and neuronal repression define familial Alzheimer’s disease
Caldwell, A. B., Liu, Q., Schroth, G. P., Galasko, D. R., Yuan, S. H., Wagner, S. L., & Subramaniam, S. (2020) · Science Advances · doi:10.1126/sciadv.aba5933 · Cited by 69
“…of cellular programs altered in both the early-onset familial and late-onset sporadic forms offers a key insight into the underlying mechanistic basis for neurodegeneration in AD and provides a basis for novel therapeutic intervention at an earlier state in the progression of the disease.”
Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration
Jiang, D., Li, T., Guo, C., Tang, T.-S., & Liu, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00953-4 · Cited by 54
The Sumo protease Senp7 is required for proper neuronal differentiation
Juarez-Vicente, F., Luna-Pelaez, N., & Garcia-Dominguez, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.028 · Cited by 30
Self-citation
Metadata
- Authors
- Garcia-Gutierrez, P., Juarez-Vicente, F., Wolgemuth, D. J., & Garcia-Dominguez, M.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2014-01-01
- Volume
- 127
- Issue
- Pt 11
- Pages
- 2554-64
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2127183015
- Cited by
- 35
- References
- 4
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.